医学
内科学
肾细胞癌
胃肠病学
乳头状肾细胞癌
皮疹
肾癌
肿瘤科
无进展生存期
肾透明细胞癌
埃罗替尼
癌症
化疗
表皮生长因子受体
作者
Ramaprasad Srinivasan,Sandeep Gurram,Eric A. Singer,Abhinav Sidana,Munjid Al Harthy,Mark W. Ball,Julia C. Friend,Lisa Mac,Erin B. Purcell,Cathy D. Vocke,Christopher J. Ricketts,Heidi H. Kong,Edward W. Cowen,Ashkan A. Malayeri,Joanna H. Shih,Maria J. Merino,W. Marston Linehan
标识
DOI：10.1056/nejmoa2200900
摘要
The combination of bevacizumab and erlotinib showed antitumor activity in patients with HLRCC-associated or sporadic papillary renal-cell carcinoma. Toxic effects were those known to be associated with this combination. (Funded by the National Cancer Institute and others; ClinicalTrials.gov number, NCT01130519.).
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
BowieHuang
浮游
shhoing
ceeray23
带头大哥
香蕉诗蕊
Criminology34
无极微光
Jared
红宝石设计局
无情的踏歌
达雨
子车茗
gexzygg
彭于彦祖
热心市民小红花
xzy998
莫问归期
小青椒
GingerF
star
niNe3YUE
核桃
寻道图强
皖公网安备34019202002308
